Background Tofacitinib is a disease-modifying antirheumatic drug (DMARD) which was recently approved by US Food and Drug Administration (FDA). There are several randomised clinical trials (RCTs ...

A new drug, Tofacitinib has gained attention for its therapeutic effects in autoimmune and inflammatory diseases. Originally approved for rheumatoid arthritis, its use in dermatology is expanding ...